Early Thimerosal Exposure and Neuropsychological Outcome at 7 and 10 Years
Investigators assessed neurological outcomes by testing more than 1,000 children aged 7 to 10 years and determined that early exposure to mercury from thimerosal-containing vaccines was not associated with deficits in neuropsychological functioning. The article was published in New England Journal of Medicine.
Author(s): Thompson W, Price C, Goodson B, et al.
Published: 2007
Visit web page (English)
(Located at content.nejm.org)
Citation: Thompson W, Price C, Goodson B, et al. Early Thimerosal Exposure and Neuropsychological Outcome at 7 and 10 Years. New England Journal of Medicine. 2007;357(13):1281-1292.
Resource types: Peer-reviewed journal
Diseases: Not disease/vaccine specific
Topics: Vaccine safety
Regions: North America and Europe
